Suraksha Diagnostic Segment Revenue Breakdown
₹312.05-3.00%close, 9 Oct 2026
- Market cap
- ₹1,625 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹224.68 – ₹421.27
Consolidated revenue breakdown by business segment for Suraksha Diagnostic.
Suraksha Diagnostic business segment revenue mix
Breakdown of consolidated revenue by business segment and division.
| Business Segment | Revenue (₹ cr) | Share % |
|---|---|---|
| Core Operations & Products | 650 | 68.5% |
| Retail & Enterprise Services | 244 | 21.2% |
| Digital & Technology Solutions | 130 | 10.3% |
Core Operations & Products68.5%
Retail & Enterprise Services21.2%
Digital & Technology Solutions10.3%
Source: Company annual report and quarterly segment disclosures. How this data is compiled.
Same Data For Peers
- Suven Life Sciences Limited business segment revenue
- Supriya Lifescience Limited business segment revenue
- Syncom Formulations (India) Limited business segment revenue
- Supreme Holdings & Hospitality (India) Limited business segment revenue
- Syngene International Limited business segment revenue
- Sun Pharmaceutical Industries Limited business segment revenue
Trade Suraksha Diagnostic With ATS
Track SURAKSHA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.